5 alpha ‐reductase inhibitor treatment for frontal fibrosing alopecia: An evidence‐based treatment update

ConclusionThis review demonstrated that FFA patients treated with 5ARI could achieve either disease stability or reduction in the rate of progression in selected cases. A well designed randomised, double‐blind, controlled study would strengthen the role of 5ARI as part of treatment armamentarium for FFA.This article is protected by copyright. All rights reserved.

http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fjdv.14930

Source: Journal of the European Academy of Dermatology and Venereology - March 10, 2018 Category: Dermatology Authors: Aizuri Murad, Wilma Bergfeld Tags: Short Report Source Type: research